Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | METRN | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Metrn (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of METRN mRNA] | CTD | PMID:22206623 | METRN | Human | 1,2-dimethylhydrazine | increases expression | ISO | Metrn (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of METRN mRNA | CTD | PMID:22206623 | METRN | Human | 17beta-estradiol | increases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of METRN mRNA | CTD | PMID:32145629 | METRN | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Metrn (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | METRN | Human | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:21394737 | METRN | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Metrn (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | METRN | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Metrn (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of METRN mRNA | CTD | PMID:21570461 and PMID:24680724 | METRN | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of METRN mRNA | CTD | PMID:33387578 | METRN | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of METRN mRNA | CTD | PMID:32109520 | METRN | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Metrn (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of METRN mRNA | CTD | PMID:30951980 | METRN | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Metrn (Mus musculus) | 6480464 | bisphenol S results in increased expression of METRN mRNA | CTD | PMID:30951980 | METRN | Human | 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | decreases expression | EXP | | 6480464 | Am 580 results in decreased expression of METRN mRNA | CTD | PMID:16982809 | METRN | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Metrn (Mus musculus) | 6480464 | Fenretinide results in decreased expression of METRN mRNA | CTD | PMID:28973697 | METRN | Human | 5-fluorouracil | multiple interactions | EXP | | 6480464 | METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 | METRN | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of METRN mRNA | CTD | PMID:24780913 | METRN | Human | acetamide | increases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | acetamide results in increased expression of METRN mRNA | CTD | PMID:31881176 | METRN | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of METRN mRNA | CTD | PMID:32763439 | METRN | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of METRN mRNA | CTD | PMID:23724009 | METRN | Human | all-trans-retinoic acid | multiple interactions | ISO | Metrn (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of METRN mRNA | CTD | PMID:30951980 | METRN | Human | antimycin A | decreases expression | EXP | | 6480464 | Antimycin A results in decreased expression of METRN mRNA | CTD | PMID:33512557 | METRN | Human | Aroclor 1254 | increases expression | ISO | Metrn (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of METRN mRNA | CTD | PMID:23650126 | METRN | Human | benzo[a]pyrene | decreases expression | ISO | Metrn (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of METRN mRNA | CTD | PMID:22228805 | METRN | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of METRN promoter | CTD | PMID:27901495 | METRN | Human | bisphenol A | decreases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of METRN mRNA | CTD | PMID:25181051 and PMID:34947998 | METRN | Human | bisphenol A | increases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of METRN mRNA | CTD | PMID:32145629 | METRN | Human | bisphenol A | increases expression | ISO | Metrn (Mus musculus) | 6480464 | bisphenol A results in increased expression of METRN mRNA | CTD | PMID:30951980 and PMID:33221593 | METRN | Human | bisphenol A | increases methylation | ISO | Metrn (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of METRN gene | CTD | PMID:28505145 | METRN | Human | bleomycin A5 | increases expression | EXP | | 6480464 | bleomycetin results in increased expression of METRN mRNA | CTD | PMID:21040473 | METRN | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of METRN mRNA | CTD | PMID:35301059 | METRN | Human | cadmium dichloride | decreases expression | ISO | Metrn (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of METRN mRNA | CTD | PMID:18974090 | METRN | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of METRN mRNA | CTD | PMID:35301059 | METRN | Human | cadmium dichloride | decreases methylation | ISO | Metrn (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of METRN promoter | CTD | PMID:22457795 | METRN | Human | carbon nanotube | increases expression | ISO | Metrn (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of METRN mRNA | CTD | PMID:25554681 | METRN | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of METRN mRNA | CTD | PMID:27392435 | METRN | Human | clobetasol | increases expression | ISO | Metrn (Mus musculus) | 6480464 | Clobetasol results in increased expression of METRN mRNA | CTD | PMID:27462272 | METRN | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of METRN mRNA | CTD | PMID:19549813 | METRN | Human | Cuprizon | decreases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of METRN mRNA | CTD | PMID:27523638 | METRN | Human | cyclophosphamide | multiple interactions | EXP | | 6480464 | METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 | METRN | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of METRN mRNA | CTD | PMID:20106945 | METRN | Human | cyclosporin A | increases expression | ISO | Metrn (Mus musculus) | 6480464 | Cyclosporine results in increased expression of METRN mRNA | CTD | PMID:19770486 | METRN | Human | deguelin | decreases expression | EXP | | 6480464 | deguelin results in decreased expression of METRN mRNA | CTD | PMID:33512557 | METRN | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of METRN mRNA | CTD | PMID:28302478 | METRN | Human | dimethylselenide | multiple interactions | EXP | | 6480464 | [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of METRN mRNA | CTD | PMID:33656867 | METRN | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of METRN mRNA | CTD | PMID:27188386 | METRN | Human | doxorubicin | multiple interactions | EXP | | 6480464 | METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 | METRN | Human | endosulfan | increases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of METRN mRNA | CTD | PMID:29391264 | METRN | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of METRN mRNA | CTD | PMID:27188386 | METRN | Human | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of METRN mRNA | CTD | PMID:26272509 | METRN | Human | ethanol | increases expression | ISO | Metrn (Mus musculus) | 6480464 | Ethanol results in increased expression of METRN mRNA | CTD | PMID:19167417 and PMID:30319688 | METRN | Human | exemestane | increases expression | EXP | | 6480464 | exemestane results in increased expression of METRN mRNA | CTD | PMID:17254854 | METRN | Human | folic acid | multiple interactions | ISO | Metrn (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of METRN mRNA] | CTD | PMID:22206623 | METRN | Human | folic acid | decreases expression | ISO | Metrn (Mus musculus) | 6480464 | Folic Acid results in decreased expression of METRN mRNA | CTD | PMID:25629700 | METRN | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of METRN mRNA | CTD | PMID:23649840 | METRN | Human | isoprenaline | decreases expression | ISO | Metrn (Mus musculus) | 6480464 | Isoproterenol results in decreased expression of METRN mRNA | CTD | PMID:20003209 | METRN | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of METRN mRNA | CTD | PMID:23649840 | METRN | Human | oxaliplatin | multiple interactions | ISO | Metrn (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of METRN mRNA | CTD | PMID:25729387 | METRN | Human | paclitaxel | multiple interactions | EXP | | 6480464 | METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 | METRN | Human | paracetamol | increases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of METRN mRNA | CTD | PMID:33387578 | METRN | Human | PCB138 | multiple interactions | ISO | Metrn (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | METRN | Human | reactive oxygen species | multiple interactions | EXP | | 6480464 | [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of METRN mRNA | CTD | PMID:33656867 | METRN | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of METRN mRNA | CTD | PMID:27188386 | METRN | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of METRN mRNA | CTD | PMID:34032870 | METRN | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of METRN mRNA | CTD | PMID:31533062 | METRN | Human | tebufenpyrad | decreases expression | EXP | | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of METRN mRNA | CTD | PMID:33512557 | METRN | Human | tetrachloroethene | decreases expression | ISO | Metrn (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of METRN mRNA | CTD | PMID:28973375 | METRN | Human | thifluzamide | decreases expression | EXP | | 6480464 | thifluzamide results in decreased expression of METRN mRNA | CTD | PMID:33512557 | METRN | Human | topotecan | decreases expression | ISO | Metrn (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of METRN mRNA | CTD | PMID:25729387 | METRN | Human | topotecan | multiple interactions | ISO | Metrn (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of METRN mRNA | CTD | PMID:25729387 | METRN | Human | trimellitic anhydride | increases expression | ISO | Metrn (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of METRN mRNA | CTD | PMID:19042947 | METRN | Human | tungsten | increases expression | ISO | Metrn (Mus musculus) | 6480464 | Tungsten results in increased expression of METRN mRNA | CTD | PMID:30912803 | METRN | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of METRN mRNA | CTD | PMID:19101580 more ... | METRN | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of METRN gene | CTD | PMID:29154799 | METRN | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of METRN mRNA | CTD | PMID:25979313 and PMID:26072468 | METRN | Human | valproic acid | affects expression | ISO | Metrn (Mus musculus) | 6480464 | Valproic Acid affects the expression of METRN mRNA | CTD | PMID:26072468 | |